INCYTE CORP (INCY) is a services-commercial physical & biological research company incorporated in DE, listed on the Nasdaq. With a market capitalization of $19.9 billion, INCYTE CORP is a large-cap company. The stock currently trades at $100.04, down 1.21% today, with a 52-week range of $53.56–$112.29. The company trades at a trailing P/E of 15.6x and a forward P/E of 11.5x.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $6.41 | $6.59 | +4173.3% | |
| 2024 | $0.15 | $0.16 | -94.3% | |
| 2023 | $2.65 | $2.67 | +74.3% | |
| 2022 | $1.52 | $1.53 | -64.4% | |
| 2021 | $4.27 | $4.30 | +527.9% | |
| 2020 | $0.68 | $0.68 | +33.3% | |
| 2019 | $0.51 | $0.51 | +59.4% | |
| 2018 | $0.32 | $0.32 | +145.1% | |
| 2017 | $-0.71 | $-0.71 | -1520.0% | |
| 2016 | $0.05 | $0.05 | -82.8% | |
| 2015 | $0.29 | $0.30 | +231.8% | |
| 2014 | $-0.22 | $-0.22 | -257.1% | |
| 2013 | $0.14 | $0.14 | +0.0% | |
| 2012 | $0.14 | $0.14 | -41.7% | |
| 2011 | $0.24 | $0.26 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-10 | 0000879169-26-000010 | SEC ↗ |
| 2024-12-31 | 2025-02-10 | 0001628280-25-004633 | SEC ↗ |
| 2023-12-31 | 2024-02-13 | 0000879169-24-000045 | SEC ↗ |
| 2022-12-31 | 2023-02-07 | 0000879169-23-000008 | SEC ↗ |
| 2021-12-31 | 2022-02-08 | 0001558370-22-000902 | SEC ↗ |
| 2020-12-31 | 2021-02-09 | 0001558370-21-000825 | SEC ↗ |
| 2019-12-31 | 2020-02-13 | 0001558370-20-000774 | SEC ↗ |
| 2018-12-31 | 2019-02-14 | 0001558370-19-000682 | SEC ↗ |